Implications of the new US AI framework in medicine
Antonis A. Armoundas · 2026
Read Implications of the new US AI framework in medicine by Antonis A. Armoundas (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13569821.txt.
Description
Antonis Armoundas weighed what the new United States policy framework for artificial intelligence means for medicine, in a 2026 commentary. AI tools are entering diagnosis, office work, and patient contact, while oversight stays split across drug rules, hospital boards, privacy law, and more. The March 2026 White House framework offers nonbinding advice to Congress rather than new law.
The framework favors fast deployment and sector-specific oversight over a single central regulator. That stance differs from the European Union's broad, risk-based model. For medicine, the author expects faster uptake, wider data access, and fewer build barriers. Yet tools that shape care but sit outside drug agency paths fall into a governance gap. He calls for stronger clinical oversight, openness, and consumer guardrails to close it.
Catalog record
| CREATOR | Antonis A. Armoundas |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |